These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5384122)

  • 41. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].
    Garpenby P
    Lakartidningen; 2004 Aug; 101(32-33):2480-2, 2484. PubMed ID: 15346621
    [No Abstract]   [Full Text] [Related]  

  • 43. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A
    Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical pharmacology (9): drug committee service].
    Boréus LO
    Lakartidningen; 1970 Apr; 67(18):2025-7. PubMed ID: 5450541
    [No Abstract]   [Full Text] [Related]  

  • 45. [The discussion on the choice of drugs requires more facts].
    Widäng K
    Lakartidningen; 1999 Sep; 96(38):4011. PubMed ID: 10526457
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of the non-hospitalised patient and the consumption of drugs].
    Bergfors PG; Hallgren CG; O'gren JE
    Lakartidningen; 1980 Mar; 77(11):1002-4. PubMed ID: 7374251
    [No Abstract]   [Full Text] [Related]  

  • 47. [Reply 1: LAKSAK supports wise drug therapy using knowledge and sharp IT-tools].
    Gustafsson LL; Hensjö LO
    Lakartidningen; 2000 Sep; 97(39):4347. PubMed ID: 11076480
    [No Abstract]   [Full Text] [Related]  

  • 48. [Open discussion on the choice of drugs is better than centralized supervision].
    Waller G
    Lakartidningen; 1999 Aug; 96(32-33):3404. PubMed ID: 10479792
    [No Abstract]   [Full Text] [Related]  

  • 49. [Work of the committee on drug side effects].
    Naes K
    Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1237-8. PubMed ID: 1162664
    [No Abstract]   [Full Text] [Related]  

  • 50. [Common Swedish-Norwegian information on drugs].
    Naess K
    Tidsskr Nor Laegeforen; 1971 May; 91(13):983-4. PubMed ID: 5576973
    [No Abstract]   [Full Text] [Related]  

  • 51. Scottish Medicines Consortium.
    Kohli HS
    Natl Med J India; 2005; 18(3):162. PubMed ID: 16130621
    [No Abstract]   [Full Text] [Related]  

  • 52. Prescribing and handling drugs in hospital.
    Lewis BJ
    Nurs Mirror Midwives J; 1970 Oct; 131(16):24-7. PubMed ID: 5203268
    [No Abstract]   [Full Text] [Related]  

  • 53. P & T Committee rises to challenges of the changing healthcare environment.
    Eybel CE; Pierpaoli PG; Carasiti ME
    Hosp Formul; 1991 Nov; 26(11):886-8, 890-4. PubMed ID: 10114819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Feedback on prescribing profiles at a primary health center. Important element in quality assurance of drug prescription].
    Nyman K; Bergens A; Björin AS; Guterstam P; Nyrén O; Jansson U; Wettermark B; Bergman U
    Lakartidningen; 2001 Jan; 98(3):160-4. PubMed ID: 11271576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [14. Cooperation between the executive committee C 6 "Dyes in medicine and biology" and dye producers].
    Gerbig KD
    Acta Histochem; 1973; Suppl 13(0):321-6. PubMed ID: 4213583
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacy and therapeutics committees in Saudi Arabia.
    Madani KA; al-Husseini TH
    Am J Hosp Pharm; 1990 Jun; 47(6):1269-70. PubMed ID: 2368713
    [No Abstract]   [Full Text] [Related]  

  • 57. Reassessing pharmacy and therapeutics committees.
    Stolar MH
    Am J Hosp Pharm; 1984 Aug; 41(8):1527. PubMed ID: 6475972
    [No Abstract]   [Full Text] [Related]  

  • 58. Editors' roundtable: Current formulas for P & T Committee success (Part 1).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Mar; 22(3):288-98. PubMed ID: 10312015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there a need for critical ethical and philosophical evaluation of hospital drugs and therapeutics (D&T) committees?
    Fijn R; van Epenhuysen LS; Peijnenburg AJ; Brouwers JR; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):247-52. PubMed ID: 12058711
    [No Abstract]   [Full Text] [Related]  

  • 60. Evolving concerns of pharmacy and therapeutics committees.
    Weintraub M
    Hosp Formul; 1980 Jan; 15(1):29-31. PubMed ID: 10244955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.